Deprescribing Diabetes Medications in Older Adults

STUDY BASICS

Are you a caregiver for an adult with diabetes? Is the adult age 65 or over? You may be eligible to participate in a research study to better understand your views on discontinuing or dose-reducing diabetes medications with risk of harm. Compensation is provided.

STUDY PURPOSE

Many older adults with diabetes are prescribed medications that can lead to harms such as falls and impaired balance. Examples of such medications include sulfonylureas or tricyclic anti-depressants to treat diabetes-related pain. The purpose of this study is to better understand your views on discontinuing or dose-reducing diabetes medications with risk of harm. We will use the results of this study to develop strategies to help these medications be discontinued or to have their doses reduced in the primary care setting. 

COULD THIS STUDY BE RIGHT FOR YOU?

Eligible participants are:

• 18 years old or older
• Caregivers for an adult (age 65 or older) with diabetes who takes medications to lower blood sugar (insulin, sulfonylurea, meglitinide) or treat diabetes-related pain (gabapentin, pregabalin)

WHAT PARTICIPANTS CAN EXPECT

The study would involve a single interview conducted over telephone or Zoom at a time that is convenient for you. The interview will last approximately 30-45 minutes and will be audio recorded. All information you provide will be kept strictly confidential and your name will not be associated with any of the results.